Randomized Trial of Infusion Set Function: Steel Versus Teflon
| العنوان: | Randomized Trial of Infusion Set Function: Steel Versus Teflon |
|---|---|
| المؤلفون: | Gina Ferrari, Kari Benasi, Darrell M. Wilson, Satya Shanmugham, Mark G. Evans, Bruce A. Buckingham, Parul J. Patel |
| المصدر: | Diabetes Technology & Therapeutics. 16:15-19 |
| بيانات النشر: | Mary Ann Liebert Inc, 2014. |
| سنة النشر: | 2014 |
| مصطلحات موضوعية: | Adult, Blood Glucose, Male, Insulin pump, medicine.medical_specialty, Time Factors, Adolescent, Infusion set, Endocrinology, Diabetes and Metabolism, Body Mass Index, Catheterization, law.invention, Endocrinology, Randomized controlled trial, law, Blood Glucose Self-Monitoring, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, Child, Infusions, Intravenous, Polytetrafluoroethylene, Monitoring, Physiologic, Glycated Hemoglobin, Type 1 diabetes, Cross-Over Studies, business.industry, technology, industry, and agriculture, Original Articles, Equipment Design, medicine.disease, Crossover study, Surgery, Medical Laboratory Technology, Catheter, Diabetes Mellitus, Type 1, Steel, Hyperglycemia, Female, business |
| الوصف: | This study compared infusion set function for up to 1 week using either a Teflon(®) (Dupont(™), Wilmington, DE) catheter or a steel catheter for insulin pump therapy in type 1 diabetes mellitus.Twenty subjects participating in a randomized, open-labeled, crossover study were asked to wear two Quick-Set(®) and two Sure-T(®) infusion sets (both from Medtronic Minimed, Northridge, CA) until the infusion set failed or was worn for 1 week. All subjects wore a MiniMed continuous glucose monitoring system for the duration of the study.One subject withdrew from the study. There were 38 weeks of Sure-T wear and 39 weeks of Quick-Set wear with no difference in the survival curves of the infusion sets. There was, however, a 15% initial failure rate with the Teflon infusion set. After 7 days, both types of infusion sets had a 64% failure rate. Overall, 30% failed because of hyperglycemia and a failed correction dose, 13% were removed for pain, 10% were pulled out by accident, 10% had erythema and/or induration of10 mm, 5% fell out because of loss of adhesion, and 4% were removed for infection. The main predictor of length of wear was the individual subject. There was no increase in hyperglycemia or daily insulin requirements when an infusion set was successfully used for 7 days (n=25 of 77 weeks).We found no difference between steel and Teflon infusion sets in their function over 7 days, although 15% of Teflon sets failed because of kinking on insertion. The strongest predictor of prolonged 7-day infusion set function was the individual subject, not the type of infusion set. |
| تدمد: | 1557-8593 1520-9156 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c99d2bab37018ea5226dd40f23a90cTest https://doi.org/10.1089/dia.2013.0119Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....f9c99d2bab37018ea5226dd40f23a90c |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15578593 15209156 |
|---|